aluates Reports

$ 0.0

Automative

Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Research Report 2026

Published Date: 2026-03-31

Report Code: QYRE-Auto-15V14018

Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Research Report 2023

BUY CHAPTERS

Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Research Report 2026

Code: QYRE-Auto-15V14018

Report

2026-03-31

Pages:114

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Tianjin Angsai Cell Genetic Engineering Co. Ltd

Qingdao Aoke Biological Development Co. Ltd

Beijing SH biotechnology Co. Ltd

Beijing Beilai Biotechnology Co. Ltd

Shanghai Aisar Biotechnology Co. Ltd

Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd

Bosheng Excellence Biotechnology (Beijing) Co. Ltd

Cellular Biomedicine Group

Guangzhou Celera Stem Cell Technology Co. Ltd.

Stem Med Pte Ltd

CryoCord Sdn Bhd

Cytopeutics Sdn Bhd

Stempeutics Research Pvt. Ltd.

Asian Institute of Gastroenterology

Beijing Han's United Biotechnology Co. Ltd

Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size

The global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market was valued at US$ 156 million in 2025 and is anticipated to reach US$ 847 million by 2032, at a CAGR of 27.7% from 2026 to 2032.

Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market

Exosomes are a type of vesicles (Extracellular Vesicles, EVs) secreted by cells to the outside of the cell, with a size of 30-150nm, a double-layer membrane structure and a saucer-like shape, and rich contents (including nucleic acids, proteins and lipids, etc.), involved in the transfer of molecules between cells. As an emerging technology, it has many problems, including accurately encoding and delivering targeted therapeutics, not to mention issues surrounding intellectual property and large-scale manufacturing. For diagnostic applications, products from Exosome Diagnostics are available; for therapeutic applications, although there are three listed companies focusing on exosomes - Capricor, Puretech and Reneuron, none of the company's products have actually been used in clinical practice.

Exosome industry in China is in the initial stage of germination and development, The exosome industry in foreign currently has a limited number of players. Geographically speaking, China holds about 80% of total market share.

This report delivers a comprehensive overview of the global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Msenchymal Stem Cell and Exosome Diagnostics and Therapies. The Msenchymal Stem Cell and Exosome Diagnostics and Therapies market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Msenchymal Stem Cell and Exosome Diagnostics and Therapies manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Report

Report Metric	Details
Report Name	Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market
Accounted market size in 2025	US$ 156 million
Forecasted market size in 2032	US$ 847 million
CAGR	27.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Type I Type II
Segment by Application	Diagnostics Therapies Skincare
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Tianjin Angsai Cell Genetic Engineering Co. Ltd, Qingdao Aoke Biological Development Co. Ltd, Beijing SH biotechnology Co. Ltd, Beijing Beilai Biotechnology Co. Ltd, Shanghai Aisar Biotechnology Co. Ltd, Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd, Beijing Han's United Biotechnology Co. Ltd, Bosheng Excellence Biotechnology (Beijing) Co. Ltd, Cellular Biomedicine Group, Guangzhou Celera Stem Cell Technology Co. Ltd., Stem Med Pte Ltd, CryoCord Sdn Bhd, Cytopeutics Sdn Bhd, Stempeutics Research Pvt Ltd, Asian Institute of Gastroenterology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Msenchymal Stem Cell and Exosome Diagnostics and Therapies companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market growing?

Ans: The Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market witnessing a CAGR of 27.7% during the forecast period 2026-2032.

What is the Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market size in 2032?

Ans: The Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market size in 2032 will be US$ 847 million.

What is the Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market share by region?

Ans: Geographically speaking, China holds about 80% of total market share.

Who are the main players in the Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market report?

Ans: The main players in the Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market are Tianjin Angsai Cell Genetic Engineering Co. Ltd, Qingdao Aoke Biological Development Co. Ltd, Beijing SH biotechnology Co. Ltd, Beijing Beilai Biotechnology Co. Ltd, Shanghai Aisar Biotechnology Co. Ltd, Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd, Beijing Han's United Biotechnology Co. Ltd, Bosheng Excellence Biotechnology (Beijing) Co. Ltd, Cellular Biomedicine Group, Guangzhou Celera Stem Cell Technology Co. Ltd., Stem Med Pte Ltd, CryoCord Sdn Bhd, Cytopeutics Sdn Bhd, Stempeutics Research Pvt Ltd, Asian Institute of Gastroenterology

What are the Application segmentation covered in the Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market report?

Ans: The Applications covered in the Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market report are Diagnostics, Therapies, Skincare

What are the Type segmentation covered in the Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market report?

Ans: The Types covered in the Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market report are Type I, Type II

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Type I

1.2.3 Type II

1.3 Market by Application

1.3.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Diagnostics

1.3.3 Therapies

1.3.4 Skincare

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Perspective (2021–2032)

2.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Growth Trends by Region

2.2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Historic Market Size by Region (2021–2026)

2.2.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Region (2027–2032)

2.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Dynamics

2.3.1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Trends

2.3.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Drivers

2.3.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Challenges

2.3.4 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players by Revenue

3.1.1 Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players by Revenue (2021–2026)

3.1.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Players (2021–2026)

3.2 Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue

3.4 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Concentration Ratio

3.4.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in 2025

3.5 Global Key Players of Msenchymal Stem Cell and Exosome Diagnostics and Therapies Head Offices and Areas Served

3.6 Global Key Players of Msenchymal Stem Cell and Exosome Diagnostics and Therapies, Products and Applications

3.7 Global Key Players of Msenchymal Stem Cell and Exosome Diagnostics and Therapies, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Breakdown Data by Type

4.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Historic Market Size by Type (2021–2026)

4.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Type (2027–2032)

5 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Breakdown Data by Application

5.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Historic Market Size by Application (2021–2026)

5.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2021–2032)

6.2 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2021–2026)

6.4 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2021–2032)

7.2 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2021–2026)

7.4 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2021–2032)

8.2 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (2021–2026)

8.4 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2021–2032)

9.2 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2021–2026)

9.4 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2021–2032)

10.2 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2021–2026)

10.4 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Tianjin Angsai Cell Genetic Engineering Co. Ltd

11.1.1 Tianjin Angsai Cell Genetic Engineering Co. Ltd Company Details

11.1.2 Tianjin Angsai Cell Genetic Engineering Co. Ltd Business Overview

11.1.3 Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.1.4 Tianjin Angsai Cell Genetic Engineering Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

11.1.5 Tianjin Angsai Cell Genetic Engineering Co. Ltd Recent Development

11.2 Qingdao Aoke Biological Development Co. Ltd

11.2.1 Qingdao Aoke Biological Development Co. Ltd Company Details

11.2.2 Qingdao Aoke Biological Development Co. Ltd Business Overview

11.2.3 Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.2.4 Qingdao Aoke Biological Development Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

11.2.5 Qingdao Aoke Biological Development Co. Ltd Recent Development

11.3 Beijing SH biotechnology Co. Ltd

11.3.1 Beijing SH biotechnology Co. Ltd Company Details

11.3.2 Beijing SH biotechnology Co. Ltd Business Overview

11.3.3 Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.3.4 Beijing SH biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

11.3.5 Beijing SH biotechnology Co. Ltd Recent Development

11.4 Beijing Beilai Biotechnology Co. Ltd

11.4.1 Beijing Beilai Biotechnology Co. Ltd Company Details

11.4.2 Beijing Beilai Biotechnology Co. Ltd Business Overview

11.4.3 Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.4.4 Beijing Beilai Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

11.4.5 Beijing Beilai Biotechnology Co. Ltd Recent Development

11.5 Shanghai Aisar Biotechnology Co. Ltd

11.5.1 Shanghai Aisar Biotechnology Co. Ltd Company Details

11.5.2 Shanghai Aisar Biotechnology Co. Ltd Business Overview

11.5.3 Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.5.4 Shanghai Aisar Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

11.5.5 Shanghai Aisar Biotechnology Co. Ltd Recent Development

11.6 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd

11.6.1 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Company Details

11.6.2 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Business Overview

11.6.3 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.6.4 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

11.6.5 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Recent Development

11.7 Beijing Han's United Biotechnology Co. Ltd

11.7.1 Beijing Han's United Biotechnology Co. Ltd Company Details

11.7.2 Beijing Han's United Biotechnology Co. Ltd Business Overview

11.7.3 Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.7.4 Beijing Han's United Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

11.7.5 Beijing Han's United Biotechnology Co. Ltd Recent Development

11.8 Bosheng Excellence Biotechnology (Beijing) Co. Ltd

11.8.1 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Company Details

11.8.2 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Business Overview

11.8.3 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.8.4 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

11.8.5 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Recent Development

11.9 Cellular Biomedicine Group

11.9.1 Cellular Biomedicine Group Company Details

11.9.2 Cellular Biomedicine Group Business Overview

11.9.3 Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.9.4 Cellular Biomedicine Group Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

11.9.5 Cellular Biomedicine Group Recent Development

11.10 Guangzhou Celera Stem Cell Technology Co. Ltd.

11.10.1 Guangzhou Celera Stem Cell Technology Co. Ltd. Company Details

11.10.2 Guangzhou Celera Stem Cell Technology Co. Ltd. Business Overview

11.10.3 Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.10.4 Guangzhou Celera Stem Cell Technology Co. Ltd. Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

11.10.5 Guangzhou Celera Stem Cell Technology Co. Ltd. Recent Development

11.11 Stem Med Pte Ltd

11.11.1 Stem Med Pte Ltd Company Details

11.11.2 Stem Med Pte Ltd Business Overview

11.11.3 Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.11.4 Stem Med Pte Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

11.11.5 Stem Med Pte Ltd Recent Development

11.12 CryoCord Sdn Bhd

11.12.1 CryoCord Sdn Bhd Company Details

11.12.2 CryoCord Sdn Bhd Business Overview

11.12.3 CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.12.4 CryoCord Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

11.12.5 CryoCord Sdn Bhd Recent Development

11.13 Cytopeutics Sdn Bhd

11.13.1 Cytopeutics Sdn Bhd Company Details

11.13.2 Cytopeutics Sdn Bhd Business Overview

11.13.3 Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.13.4 Cytopeutics Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

11.13.5 Cytopeutics Sdn Bhd Recent Development

11.14 Stempeutics Research Pvt Ltd

11.14.1 Stempeutics Research Pvt Ltd Company Details

11.14.2 Stempeutics Research Pvt Ltd Business Overview

11.14.3 Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.14.4 Stempeutics Research Pvt Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

11.14.5 Stempeutics Research Pvt Ltd Recent Development

11.15 Asian Institute of Gastroenterology

11.15.1 Asian Institute of Gastroenterology Company Details

11.15.2 Asian Institute of Gastroenterology Business Overview

11.15.3 Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction

11.15.4 Asian Institute of Gastroenterology Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

11.15.5 Asian Institute of Gastroenterology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Tianjin Angsai Cell Genetic Engineering Co. Ltd

Qingdao Aoke Biological Development Co. Ltd

Beijing SH biotechnology Co. Ltd

Beijing Beilai Biotechnology Co. Ltd

Shanghai Aisar Biotechnology Co. Ltd

Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd

Bosheng Excellence Biotechnology (Beijing) Co. Ltd

Cellular Biomedicine Group

Guangzhou Celera Stem Cell Technology Co. Ltd.

Stem Med Pte Ltd

CryoCord Sdn Bhd

Cytopeutics Sdn Bhd

Stempeutics Research Pvt. Ltd.

Asian Institute of Gastroenterology

Beijing Han's United Biotechnology Co. Ltd

List of Tables

Table 1. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Type I

Table 3. Key Players of Type II

Table 4. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (US$ Million), 2021–2026

Table 7. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Region (2021–2026)

Table 8. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Region (2027–2032)

Table 10. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Trends

Table 11. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Drivers

Table 12. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Challenges

Table 13. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Restraints

Table 14. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue by Players (US$ Million), 2021–2026

Table 15. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Players (2021–2026)

Table 16. Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players by Tier (Tier 1, Tier 2, and Tier 3), based on Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2025

Table 17. Ranking of Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Msenchymal Stem Cell and Exosome Diagnostics and Therapies, Headquarters and Area Served

Table 20. Global Key Players of Msenchymal Stem Cell and Exosome Diagnostics and Therapies, Products and Applications

Table 21. Global Key Players of Msenchymal Stem Cell and Exosome Diagnostics and Therapies, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type (US$ Million), 2021–2026

Table 24. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Type (2021–2026)

Table 25. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Type (2027–2032)

Table 27. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application (US$ Million), 2021–2026

Table 28. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Application (2021–2026)

Table 29. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Application (2027–2032)

Table 31. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (US$ Million), 2021–2026

Table 33. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (US$ Million), 2027–2032

Table 46. Tianjin Angsai Cell Genetic Engineering Co. Ltd Company Details

Table 47. Tianjin Angsai Cell Genetic Engineering Co. Ltd Business Overview

Table 48. Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 49. Tianjin Angsai Cell Genetic Engineering Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (US$ Million), 2021–2026

Table 50. Tianjin Angsai Cell Genetic Engineering Co. Ltd Recent Development

Table 51. Qingdao Aoke Biological Development Co. Ltd Company Details

Table 52. Qingdao Aoke Biological Development Co. Ltd Business Overview

Table 53. Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 54. Qingdao Aoke Biological Development Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (US$ Million), 2021–2026

Table 55. Qingdao Aoke Biological Development Co. Ltd Recent Development

Table 56. Beijing SH biotechnology Co. Ltd Company Details

Table 57. Beijing SH biotechnology Co. Ltd Business Overview

Table 58. Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 59. Beijing SH biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (US$ Million), 2021–2026

Table 60. Beijing SH biotechnology Co. Ltd Recent Development

Table 61. Beijing Beilai Biotechnology Co. Ltd Company Details

Table 62. Beijing Beilai Biotechnology Co. Ltd Business Overview

Table 63. Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 64. Beijing Beilai Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (US$ Million), 2021–2026

Table 65. Beijing Beilai Biotechnology Co. Ltd Recent Development

Table 66. Shanghai Aisar Biotechnology Co. Ltd Company Details

Table 67. Shanghai Aisar Biotechnology Co. Ltd Business Overview

Table 68. Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 69. Shanghai Aisar Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (US$ Million), 2021–2026

Table 70. Shanghai Aisar Biotechnology Co. Ltd Recent Development

Table 71. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Company Details

Table 72. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Business Overview

Table 73. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 74. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (US$ Million), 2021–2026

Table 75. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Recent Development

Table 76. Beijing Han's United Biotechnology Co. Ltd Company Details

Table 77. Beijing Han's United Biotechnology Co. Ltd Business Overview

Table 78. Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 79. Beijing Han's United Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (US$ Million), 2021–2026

Table 80. Beijing Han's United Biotechnology Co. Ltd Recent Development

Table 81. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Company Details

Table 82. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Business Overview

Table 83. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 84. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (US$ Million), 2021–2026

Table 85. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Recent Development

Table 86. Cellular Biomedicine Group Company Details

Table 87. Cellular Biomedicine Group Business Overview

Table 88. Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 89. Cellular Biomedicine Group Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (US$ Million), 2021–2026

Table 90. Cellular Biomedicine Group Recent Development

Table 91. Guangzhou Celera Stem Cell Technology Co. Ltd. Company Details

Table 92. Guangzhou Celera Stem Cell Technology Co. Ltd. Business Overview

Table 93. Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 94. Guangzhou Celera Stem Cell Technology Co. Ltd. Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (US$ Million), 2021–2026

Table 95. Guangzhou Celera Stem Cell Technology Co. Ltd. Recent Development

Table 96. Stem Med Pte Ltd Company Details

Table 97. Stem Med Pte Ltd Business Overview

Table 98. Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 99. Stem Med Pte Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (US$ Million), 2021–2026

Table 100. Stem Med Pte Ltd Recent Development

Table 101. CryoCord Sdn Bhd Company Details

Table 102. CryoCord Sdn Bhd Business Overview

Table 103. CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 104. CryoCord Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (US$ Million), 2021–2026

Table 105. CryoCord Sdn Bhd Recent Development

Table 106. Cytopeutics Sdn Bhd Company Details

Table 107. Cytopeutics Sdn Bhd Business Overview

Table 108. Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 109. Cytopeutics Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (US$ Million), 2021–2026

Table 110. Cytopeutics Sdn Bhd Recent Development

Table 111. Stempeutics Research Pvt Ltd Company Details

Table 112. Stempeutics Research Pvt Ltd Business Overview

Table 113. Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 114. Stempeutics Research Pvt Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (US$ Million), 2021–2026

Table 115. Stempeutics Research Pvt Ltd Recent Development

Table 116. Asian Institute of Gastroenterology Company Details

Table 117. Asian Institute of Gastroenterology Business Overview

Table 118. Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product

Table 119. Asian Institute of Gastroenterology Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (US$ Million), 2021–2026

Table 120. Asian Institute of Gastroenterology Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Picture

Figure 2. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Type: 2025 vs 2032

Figure 4. Type I Features

Figure 5. Type II Features

Figure 6. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Application: 2025 vs 2032

Figure 8. Diagnostics Case Studies

Figure 9. Therapies Case Studies

Figure 10. Skincare Case Studies

Figure 11. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Report Years Considered

Figure 12. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Region: 2025 vs 2032

Figure 15. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Players in 2025

Figure 16. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in 2025

Figure 18. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2021–2032)

Figure 20. United States Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2021–2032)

Figure 24. Germany Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Region (2021–2032)

Figure 32. China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2021–2032)

Figure 40. Mexico Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2021–2032)

Figure 44. Israel Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Tianjin Angsai Cell Genetic Engineering Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

Figure 48. Qingdao Aoke Biological Development Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

Figure 49. Beijing SH biotechnology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

Figure 50. Beijing Beilai Biotechnology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

Figure 51. Shanghai Aisar Biotechnology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

Figure 52. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

Figure 53. Beijing Han's United Biotechnology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

Figure 54. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

Figure 55. Cellular Biomedicine Group Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

Figure 56. Guangzhou Celera Stem Cell Technology Co. Ltd. Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

Figure 57. Stem Med Pte Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

Figure 58. CryoCord Sdn Bhd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

Figure 59. Cytopeutics Sdn Bhd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

Figure 60. Stempeutics Research Pvt Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

Figure 61. Asian Institute of Gastroenterology Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021–2026)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic